grifols shanghai raas
With this transaction Grifols will control a 262 stake in Shanghai RAAS capital economic and voting rights in exchange for a non-majority share in Grifols Diagnostics Solutions 45 economic and 40 voting rights. Subsidiary of Spanish blood products company Grifols the. Grifols Ostentara Una Participacion Del 26 2 En La China Shanghai Raas Tras Cerrar Su Alianza Estrategica Grifols and Shanghai RAAS close their strategic alliance in China Grifols controls a 2620 stake in Shanghai RAAS economic and voting rights in exchange for a non-majority share on behalf of Shanghai RAAS 45 economic rights and 40 voting rights in Grifols subsidiary Grifols Diagnostic Solutions GDS. . Barcelona November 13 2019- Grifols MCEGRF MCEGRFP NASDAQGRFS a global healthcare company with a track record of more than 100 years dedicated to enhancing peoples health and well-being and a leader in plasma medicines transfusion diagnosis and pharmaceutical specialties for